Antibodies to 125I-glutamic acid decarboxylase in patients with stiff man syndrome

Journal of Neurology Neurosurgery and Psychiatry

Volumn 62, Issue 4, 1997, Pages 395-397

  Vincent, Angela ^a   Grimaldi, Luigi M E ^b   Martino, Gianvito ^b   Davenport, Claire ^c   Todd, Ian ^c  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Glutamic acid decarboxylase; Neuromyotonia; Stiff man syndrome

Indexed keywords

ANTIBODY; GLUTAMATE DECARBOXYLASE; IODINE 125;

ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; HUMAN; IMMUNOASSAY; IMMUNOPRECIPITATION; MYASTHENIA GRAVIS; PRIORITY JOURNAL; STIFF MAN SYNDROME; THYMOMA; BLOOD; CEREBROSPINAL FLUID; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; IMMUNOLOGY;

ANTIBODIES; FEMALE; GLUTAMATE DECARBOXYLASE; HUMANS; STIFF-PERSON SYNDROME;

EID: 0030612040     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.62.4.395     Document Type: Article

References (15)

1. Pender MP. The stiff-man syndrome. In: MP Pender, PA McCombe, eds. Autoimmune neurological disease. Cambridge: Cambridge University Press, 1995.
2. Solimena M, Folli F, Denis Donin S, et al. Autoantibodies to glutamic acid decarboxylase in a patient with stiff-man syndrome, epilepsy, and type I diabetes mellitus. N Engl J Med 1988;318:1012-20.
3. Solimena M, Folli F, Aparisi R, Pozza G, De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med 1990; 322:1555-60.
4. Grimadi LM, Martino G, Braghi S, et al. Heterogeneity of autoantibodies in stiff-man syndrome. Ann Neurol 1993; 34:57-64.
5. Martino GV, Tappaz ML, Braghi S, et al. Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immune-trapping enzyme activity assay: relation to insulin-dependent diabetes and islet cell antibodies. J Autoimmun 1991;4:915-23.
6. Folli F, Solimena M, Cornell R, et al. Autoantibodies to a 128-kD synaptic protein in three women with the stiffman syndrome and breast cancer. N Engl J Med 1993; 328:546-51.
7. De Camilli P, Thomas A, Cofiell R, et al. The synaptic vesicle-associated protein amphiphysin is the 128-kD autoantigen of stiff-man syndrome with breast cancer. J Exp Med 1993:178:2219-23.
8. Schmidli RS, Colman PG, Bonifacio E. Disease sensitivity and specificity of 52 assays for glutamic acid decarboxylase antibodies. Diabetes 1995:44:636-40.
9. Shillito P, Molenaar PC, Vincent A, et al. Acquired neuromyotonia: evidence for autoantibodies against K+ channels of peripheral nerves. Ann Neurol 1995;38: 714-22.
10. Vicari AM, Folli F, Pozza G, et al. Plasmapheresis in the treatment of stiff-man syndrome. N Engl J Med 1989; 320:1499.
11. Harding AE, Thompson PD, Kocen RS, et al. Plasma exchange and immunosuppression in the stiff-man syndrome. Lancet 1989;ii:915.
12. Brashear HR, Phillips LH. Autoantibodies to GABAergic neurons and response to plasmapheresis in stiff-man syndrome. Neurology 1991:41:1588-92.
13. Sinha S, Newsom-Davis J, Mills K, et al. Autoimmune aetiology for acquired neuromyotoma (Isaacs' syndrome). Lancet 1991;338:75-7.
14. + channels are implicated in neuromyotonia. Ann Neurol 1996 (in press).
15. Newsom-Davis J, Mills KR. Immunological associations of acquired neuromyotonia (Isaacs' syndrome). Report of five cases and literature review. Brain 1993;116:453-69.